Search
News
Vuzix Q2 2026 earnings: Revenue fell as operating cash use increased
Vuzix reported Q2 2026 revenue of $1.1 million, down 14% year over year, while loss per share narrowed to $0.09 from $0.10. The gross loss improved, but liquidity pressure increased as operating cash use rose to $6.6 million from $4.8 million. Product and engineering-services sales both declined despite customer milestones involving Amazon, Collins Aerospace, a global automaker and Augmex. Continued R&D and waveguide-manufacturing investment remains central to Vuzix’s strategy, making commercialization progress and cash consumption the main issues to monitor.
TradingKey
Thu, Aug 13
HawkEye 360 Q2 2026 earnings: Revenue grows 87% but GAAP profitability reverses
HawkEye 360 reported Q2 2026 revenue of $49.8 million, up 87% year over year, while diluted EPS swung to a $0.07 loss from $0.01 profit. International revenue reached a record $21.0 million, but higher operating costs pushed the company to a $15.3 million GAAP net loss and reduced adjusted EBITDA to $7.0 million. Quarterly free cash flow improved to $5.4 million, and the May IPO lifted cash and cash equivalents to $503.4 million. Full-year guidance calls for $215 million to $220 million in revenue.
TradingKey
Thu, Aug 13
AudioEye Q2 2026 Earnings: Adjusted EBITDA Reaches a Record $3.0 Million
AudioEye’s Q2 2026 earnings showed revenue rising 9% year over year to a record $10.7 million, while adjusted EBITDA increased to a record $3.0 million from $1.9 million. GAAP net loss widened to $0.9 million, or $0.07 per share, as the prior-year quarter benefited from a $1.4 million contingent-consideration gain and current litigation costs increased. ARR reached $42.3 million, up 11% year over year. The company raised full-year adjusted EBITDA guidance to at least $12.7 million while projecting 2026 revenue of $43.5 million to $44.0 million.
TradingKey
Thu, Aug 13
MultiSensor AI Q2 2026 Earnings: Software Growth Narrows Losses
MultiSensor AI’s Q2 2026 revenue increased 19% to $1.7 million, led by an 85% rise in software revenue to $0.7 million, while net loss narrowed 26% to $2.5 million. Diluted loss per share improved to $1.19 from $3.96, although the larger weighted-average share count contributed to that change. Lower costs improved operating leverage, but six-month operating cash outflow edged up to $4.1 million as receivables grew. Cash ended June at $21.0 million, with a 10-site rollout planned for the second half.
TradingKey
Thu, Aug 13
NeuroOne Fiscal Q3 2026 Earnings: Gross Margin Expands as Net Loss Widens
NeuroOne’s fiscal Q3 2026 product revenue rose 16% to $2.0 million, while product gross margin expanded to a record 59.9% from 53.9%. The company’s net loss widened to $2.0 million from $1.5 million as operating expenses increased to $3.6 million. New product orders reached $2.7 million, exceeding quarterly recognized revenue and lifting backlog to $1.7 million, but cash and working capital declined from fiscal year-end levels as NeuroOne continued funding sales, development, and commercialization activities, with no debt at quarter-end.
TradingKey
Thu, Aug 13
NextPlat Q2 2026 Earnings: Gross Margin Reaches 40% as Loss Narrows
NextPlat’s Q2 2026 revenue was $11.9 million, down about 10% year over year but up 21% sequentially. Gross margin reached approximately 40%, compared with 22% a year earlier, as higher-margin 340B and medication fulfillment services improved the healthcare mix. Net loss attributable to common stockholders narrowed to $144,000, or $0.05 per diluted share, from $1.8 million, or $0.69 per share. Contracted pharmacy revenue rose 136% to $2.2 million, while total pharmacy prescription revenue declined amid lower reimbursement rates and payer mix.TradingKey
Thu, Aug 13
ADC Therapeutics Q2 2026 Earnings: Lower Spending Narrows the Loss
ADC Therapeutics’ Q2 2026 results showed total revenue of $19.2 million, including $18.6 million in net product revenue, while GAAP loss per share narrowed to $0.11 from $0.50. Total operating expenses fell 29% to $44.7 million, led by lower R&D and restructuring costs, and net loss improved to $16.6 million from $56.6 million. Cash was $219.1 million as of June 30, with runway expected at least into 2028. However, FDA concerns about LOTIS-5’s benefit-risk profile leave ZYNLONTA’s full-approval path under review.
TradingKey
Thu, Aug 13
McGraw Hill Fiscal Q1 2027 Earnings: Margin Expansion Outpaces Revenue Growth
McGraw Hill (NYSE: MH) reported fiscal first quarter 2027 revenue of $549.9 million, up 2.6% year over year, while diluted EPS rose to $0.30 from $0.00. GAAP gross margin expanded 290 basis points to 79.9%, and adjusted EBITDA increased 8.2% to $207.0 million. Higher Education led segment growth with a 9.6% revenue increase, while K-12 grew 1.3%. Operating cash flow improved to $0.6 million from a $96.7 million outflow, though cash declined as product development and capital spending continued.
TradingKey
Thu, Aug 13
VENU Fiscal Q2 2026 Earnings: Asset Growth Raises Financing Demands
VENU’s fiscal Q2 2026 earnings release showed six-month revenue of $8.5 million, up 7%, while the six-month net loss widened to $34.2 million and operating cash use improved to $9.4 million. Total assets reached $511.8 million at June 30, up 38% from year-end, as property and equipment climbed to $446.2 million amid heavy venue construction. The key issue is financing: capital spending drove a $25.0 million cash decline, while VENU raised equity and other funding and outlined more than $150 million of post-quarter C-PACE financing.
TradingKey
Thu, Aug 13
Accelerant Q2 2026 Earnings: Exchange Premium Rises 23%
Accelerant (NYSE: ARX) reported Q2 2026 total revenue of $356.9 million, up about 63% year over year, while diluted EPS rose to $0.36 from $0.04. Exchange Written Premium increased 23% to $1.32 billion, and adjusted EBITDA reached $93.1 million with a 30.6% margin. Growth was supported by a larger third-party premium mix, although $53.0 million of investment gains amplified GAAP results. The company also disclosed negative first-half operating cash flow and withheld forward guidance following its pending Thoma Bravo acquisition agreement.
TradingKey
Thu, Aug 13
Stratasys Q2 2026 Earnings: Record Consumables Amid Flat Revenue
Stratasys (NASDAQ: SSYS) reported Q2 2026 revenue of $137.6 million, down about 0.3% year over year but up 3.7% sequentially. GAAP net loss was $16.9 million, or $0.19 per diluted share, while non-GAAP EPS held at $0.03. Record consumables revenue of $66.3 million and 17% aerospace and defense growth supported the quarter, but adjusted EBITDA fell to $5.3 million and operating cash use rose to $18.7 million. The company reaffirmed most 2026 guidance while withdrawing its expectation for positive full-year operating cash flow.
TradingKey
Thu, Aug 13
Buda Juice Q2 2026 Earnings: Revenue Growth Came With Margin Pressure
Buda Juice’s Q2 2026 earnings showed revenue rising 26.4% to $4.5 million, while gross margin fell to 36.6% from 46.7% and free cash flow was negative $0.8 million. Same-store beverage growth, distribution into 246 Walmart stores and acquired dressings operations supported sales. Temporary co-packing, elevated lime and freight costs, training investments and a higher public-company cost base pressured profit. The company ended June debt-free, while preliminary net sales for the first six weeks of Q3 increased more than 40% year over year.
TradingKey
Thu, Aug 13
Nomad Foods Q2 2026 earnings: Gross margin improves despite lower volume
Nomad Foods’ Q2 2026 revenue fell 3.1% to €723.7 million as a 5.9% volume decline outweighed a 3.0% price-mix benefit. Adjusted gross margin rose 110 basis points to 28.9% on pricing and supply-chain productivity, but adjusted EBITDA declined 4.3% to €123.7 million and adjusted EPS slipped to €0.39. Reported profit also fell 15%. The company maintained its organic revenue, EBITDA and cash-conversion outlooks while lowering full-year adjusted EPS guidance to €1.38-€1.53 because of higher interest expense following recently completed refinancing and higher variable interest rates.
TradingKey
Thu, Aug 13
Applied Industrial Technologies Q4 FY2026 earnings: Organic growth lifts EBITDA margin
Applied Industrial Technologies reported fiscal Q4 2026 net sales of $1.353 billion, up 10.4% year over year, with organic growth of 9.7%. Diluted EPS increased 13.2% to $3.17, while non-GAAP EBITDA rose 16.1% to $177.6 million and margin expanded by roughly 60 basis points. Engineered Solutions led segment growth, though Service Center produced the larger margin gain. Fiscal 2027 guidance calls for 4.0% to 6.5% total sales growth, EPS of $11.65 to $12.15, and a 12.5% to 12.8% EBITDA margin.
TradingKey
Thu, Aug 13
SBC Medical Q2 2026 Earnings: Revenue Reaccelerates as Margins Expand
SBC Medical’s fiscal Q2 2026 revenue rose 13% year over year to $49.2 million, while basic and diluted EPS increased to $0.10 from $0.02. Net income attributable to the company reached $10.7 million, and adjusted EBITDA rose 32% to $20 million with a 41% margin. Near-flat cost of revenue, service-fee increases, growth in the points business, lower tax expense, and a favorable foreign-exchange swing supported the quarter, though first-half net income and adjusted EBITDA remained below prior-year levels.
TradingKey
Thu, Aug 13
AIRO Q2 2026 Earnings: Drone Mix Lifts Gross Margin to 64%
AIRO Group Holdings’ Q2 2026 revenue rose 76% to $43.2 million, while diluted EPS moved to a $0.06 loss from $0.30 of earnings a year earlier. A favorable shift toward higher-margin drone products lifted gross margin to 64% and returned the company to operating profitability, even as GAAP net income turned negative because prior-year other-income benefits did not recur and current tax expense exceeded pretax income. AIRO also reiterated its full-year 2026 revenue-growth and adjusted EBITDA outlook without changes.TradingKey
Thu, Aug 13
Direct Digital Q2 2026 earnings: DSP spending decline cuts revenue 23%
Direct Digital Holdings reported Q2 2026 revenue of $7.8 million, down 23% year over year as DSP customer spending fell by $2.5 million to zero. Gross margin slipped to 34%, operating loss widened to $2.9 million, and adjusted EBITDA loss increased to $2.3 million, although consolidated net loss narrowed to $3.6 million on lower interest expense. Excluding DSP customers, revenue rose 3%. Cash stood at $0.5 million at June 30, while credit-facility covenant noncompliance made liquidity and lender negotiations central issues.
TradingKey
Wed, Aug 12
Pelagos Q2 2026 earnings: Reserve development offsets higher catastrophe losses
Pelagos Insurance Capital’s Q2 2026 results included gross premiums written of $1.297 billion, up 6.4% year over year, diluted EPS of $0.52 versus $0.18, and net income of $44.4 million. The combined ratio improved to 99.5% from 103.7% as $32.7 million of favorable prior-year reserve development helped offset $161.8 million of catastrophe and large losses. Insurance underwriting income increased, while Reinsurance premium growth was accompanied by lower net premiums earned due to business mix. Attritional losses and higher expenses remain important operating pressures.TradingKey
Wed, Aug 12
BitGo Q2 2026 Earnings: Revenue Rose 80% but Transaction Margins Narrowed
BitGo (NYSE: BTGO) reported Q2 2026 revenue of $4.329 billion, up 79.6% year over year, but posted a $19.0 million net loss and diluted EPS of $(0.16), compared with net income of $38.3 million and diluted EPS of $0.28 a year earlier. Digital Asset Sales drove the top-line increase, yet its margin narrowed to 17 basis points, while the staking take rate fell to 6.0%. Normalized assets on platform rose 31.4%, and management outlined approximately $15 million in expected annualized cash savings.TradingKey
Wed, Aug 12
WhiteHawk Q2 2026 earnings: IPO costs obscure record production and higher EBITDA
WhiteHawk Minerals’ Q2 2026 revenue rose 38% to $29.1 million as record production reached 70.0 MMcfe/d, up 57% year over year. Adjusted EBITDA more than doubled to $20.7 million, but IPO and reorganization costs pushed the company to a GAAP net loss. The quarter also brought signed mineral and royalty acquisitions and a new quarterly dividend, making acquisition financing, hedge support, and cash available for distribution central to the outlook as WhiteHawk moves from its IPO period into expansion.TradingKey
Wed, Aug 12
Featured Tools
Top News
The Week Ahead: Fed Minutes, Walmart, Target and Home Depot Earnings to Test US Consumer Resilience
Canadian Dollar: CPI and US tariffs weigh on outlook – BBH
Broadcom Stock Price Forecast: Can It Break $500 Before Earnings Amid Strong Custom AI Chip Demand?
SK Hynix Stock Forecast: Can HBM4 Demand Drive a Breakout Toward $194?
Tesla Stock Price Prediction: SpaceX Thruster-Equipped Roadster May Debut This Month, Could It Boost TSLA Stock?
